F&FFinancial Insights

Financial Metrics

NSC NORFOLK SOUTHERN CORP
Range: 2016-01-01 to 2026-04-29
Export Quarterly CSV Export Annual CSV
Chart Range:
% Change:

Financial Statements

Grouped by statement

Income Statement

Metrics: 6

Revenue

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2016-03-31 2420000000.0 — USD 10-Q 2017-04-26
Quarterly 2016-06-30 2454000000.0 +1.4% USD 10-Q 2017-07-26
Quarterly 2016-09-30 2524000000.0 +2.9% USD 10-Q 2017-10-25
Quarterly 2017-03-31 2575000000.0 +2.0% USD 10-Q 2018-04-25
Quarterly 2017-06-30 2637000000.0 +2.4% USD 10-Q 2018-07-25
Quarterly 2017-09-30 2670000000.0 +1.3% USD 10-Q 2018-10-24
Quarterly 2018-03-31 2717000000.0 +1.8% USD 10-Q 2019-04-24
Quarterly 2018-06-30 2898000000.0 +6.7% USD 10-Q 2019-07-24
Quarterly 2018-09-30 2947000000.0 +1.7% USD 10-Q 2019-10-23
Quarterly 2019-03-31 2840000000.0 -3.6% USD 10-Q 2020-04-29
Quarterly 2019-06-30 2925000000.0 +3.0% USD 10-Q 2020-07-29
Quarterly 2019-09-30 2841000000.0 -2.9% USD 10-Q 2020-10-28
Quarterly 2020-03-31 2625000000.0 -7.6% USD 10-Q 2021-04-28
Quarterly 2020-06-30 2085000000.0 -20.6% USD 10-Q 2021-07-28
Quarterly 2020-09-30 2506000000.0 +20.2% USD 10-Q 2021-10-27
Quarterly 2021-03-31 2639000000.0 +5.3% USD 10-Q 2022-04-27
Quarterly 2021-06-30 2799000000.0 +6.1% USD 10-Q 2022-07-27
Quarterly 2021-09-30 2852000000.0 +1.9% USD 10-Q 2022-10-26
Quarterly 2022-03-31 2915000000.0 +2.2% USD 10-Q 2023-04-26
Quarterly 2022-06-30 3250000000.0 +11.5% USD 10-Q 2023-07-27
Quarterly 2022-09-30 3343000000.0 +2.9% USD 10-Q 2023-10-25
Quarterly 2023-03-31 3132000000.0 -6.3% USD 10-Q 2024-04-24
Quarterly 2023-06-30 2980000000.0 -4.9% USD 10-Q 2024-07-26
Quarterly 2023-09-30 2971000000.0 -0.3% USD 10-Q 2024-10-22
Quarterly 2024-03-31 3004000000.0 +1.1% USD 10-Q 2025-04-23
Quarterly 2024-06-30 3044000000.0 +1.3% USD 10-Q 2025-07-29
Quarterly 2024-09-30 3051000000.0 +0.2% USD 10-Q 2025-10-23
Quarterly 2025-03-31 2993000000.0 -1.9% USD 10-Q 2025-04-23
Quarterly 2025-06-30 3110000000.0 +3.9% USD 10-Q 2025-07-29
Quarterly 2025-09-30 3103000000.0 -0.2% USD 10-Q 2025-10-23
Annual 2016-12-31 9888000000.0 — USD 10-K 2019-02-08
Annual 2017-12-31 10551000000.0 +6.7% USD 10-K 2020-02-06
Annual 2018-12-31 11458000000.0 +8.6% USD 10-K 2021-02-04
Annual 2019-12-31 11296000000.0 -1.4% USD 10-K 2022-02-04
Annual 2020-12-31 9789000000.0 -13.3% USD 10-K 2023-02-03
Annual 2021-12-31 11142000000.0 +13.8% USD 10-K 2024-02-05
Annual 2022-12-31 12745000000.0 +14.4% USD 10-K 2025-02-10
Annual 2023-12-31 12156000000.0 -4.6% USD 10-K 2026-02-09
Annual 2024-12-31 12123000000.0 -0.3% USD 10-K 2026-02-09
Annual 2025-12-31 12180000000.0 +0.5% USD 10-K 2026-02-09

Gross Profit

Q: 0 | A: 0

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed

Operating Income

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2016-03-31 723000000.0 — USD 10-Q 2017-04-26
Quarterly 2016-06-30 770000000.0 +6.5% USD 10-Q 2017-07-26
Quarterly 2016-09-30 820000000.0 +6.5% USD 10-Q 2017-10-25
Quarterly 2017-03-31 757000000.0 -7.7% USD 10-Q 2018-04-25
Quarterly 2017-06-30 872000000.0 +15.2% USD 10-Q 2018-07-25
Quarterly 2017-09-30 895000000.0 +2.6% USD 10-Q 2018-10-24
Quarterly 2018-03-31 835000000.0 -6.7% USD 10-Q 2019-04-24
Quarterly 2018-06-30 1026000000.0 +22.9% USD 10-Q 2019-07-24
Quarterly 2018-09-30 1020000000.0 -0.6% USD 10-Q 2019-10-23
Quarterly 2019-03-31 966000000.0 -5.3% USD 10-Q 2020-04-29
Quarterly 2019-06-30 1065000000.0 +10.2% USD 10-Q 2020-07-29
Quarterly 2019-09-30 996000000.0 -6.5% USD 10-Q 2020-10-28
Quarterly 2020-03-31 568000000.0 -43.0% USD 10-Q 2021-04-28
Quarterly 2020-06-30 610000000.0 +7.4% USD 10-Q 2021-07-28
Quarterly 2020-09-30 840000000.0 +37.7% USD 10-Q 2021-10-27
Quarterly 2021-03-31 1015000000.0 +20.8% USD 10-Q 2022-04-27
Quarterly 2021-06-30 1167000000.0 +15.0% USD 10-Q 2022-07-27
Quarterly 2021-09-30 1136000000.0 -2.7% USD 10-Q 2022-10-26
Quarterly 2022-03-31 1085000000.0 -4.5% USD 10-Q 2023-04-26
Quarterly 2022-06-30 1271000000.0 +17.1% USD 10-Q 2023-07-27
Quarterly 2022-09-30 1272000000.0 +0.1% USD 10-Q 2023-10-25
Quarterly 2023-03-31 711000000.0 -44.1% USD 10-Q 2024-04-24
Quarterly 2023-06-30 576000000.0 -19.0% USD 10-Q 2024-07-26
Quarterly 2023-09-30 756000000.0 +31.2% USD 10-Q 2024-10-22
Quarterly 2024-03-31 213000000.0 -71.8% USD 10-Q 2025-04-23
Quarterly 2024-06-30 1131000000.0 +431.0% USD 10-Q 2025-07-29
Quarterly 2024-09-30 1596000000.0 +41.1% USD 10-Q 2025-10-23
Quarterly 2025-03-31 1146000000.0 -28.2% USD 10-Q 2025-04-23
Quarterly 2025-06-30 1175000000.0 +2.5% USD 10-Q 2025-07-29
Quarterly 2025-09-30 1098000000.0 -6.6% USD 10-Q 2025-10-23
Annual 2016-12-31 3009000000.0 — USD 10-K 2019-02-08
Annual 2017-12-31 3522000000.0 +17.0% USD 10-K 2020-02-06
Annual 2018-12-31 3959000000.0 +12.4% USD 10-K 2021-02-04
Annual 2019-12-31 3989000000.0 +0.8% USD 10-K 2022-02-04
Annual 2020-12-31 3002000000.0 -24.7% USD 10-K 2023-02-03
Annual 2021-12-31 4447000000.0 +48.1% USD 10-K 2024-02-05
Annual 2022-12-31 4809000000.0 +8.1% USD 10-K 2025-02-10
Annual 2023-12-31 2851000000.0 -40.7% USD 10-K 2026-02-09
Annual 2024-12-31 4071000000.0 +42.8% USD 10-K 2026-02-09
Annual 2025-12-31 4356000000.0 +7.0% USD 10-K 2026-02-09

Net Income

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2016-03-31 387000000.0 — USD 10-Q 2017-04-26
Quarterly 2016-06-30 405000000.0 +4.7% USD 10-Q 2017-07-26
Quarterly 2016-09-30 460000000.0 +13.6% USD 10-Q 2017-10-25
Quarterly 2017-03-31 433000000.0 -5.9% USD 10-Q 2018-04-25
Quarterly 2017-06-30 497000000.0 +14.8% USD 10-Q 2018-07-25
Quarterly 2017-09-30 506000000.0 +1.8% USD 10-Q 2018-10-24
Quarterly 2018-03-31 552000000.0 +9.1% USD 10-Q 2019-10-23
Quarterly 2018-06-30 710000000.0 +28.6% USD 10-Q 2019-10-23
Quarterly 2018-09-30 702000000.0 -1.1% USD 10-Q 2019-10-23
Quarterly 2019-03-31 677000000.0 -3.6% USD 10-Q 2020-10-28
Quarterly 2019-06-30 722000000.0 +6.6% USD 10-Q 2020-10-28
Quarterly 2019-09-30 657000000.0 -9.0% USD 10-Q 2020-10-28
Quarterly 2020-03-31 381000000.0 -42.0% USD 10-Q 2021-10-27
Quarterly 2020-06-30 392000000.0 +2.9% USD 10-Q 2021-10-27
Quarterly 2020-09-30 569000000.0 +45.2% USD 10-Q 2021-10-27
Quarterly 2021-03-31 673000000.0 +18.3% USD 10-Q 2022-10-26
Quarterly 2021-06-30 819000000.0 +21.7% USD 10-Q 2022-10-26
Quarterly 2021-09-30 753000000.0 -8.1% USD 10-Q 2022-10-26
Quarterly 2022-03-31 703000000.0 -6.6% USD 10-Q 2023-10-25
Quarterly 2022-06-30 819000000.0 +16.5% USD 10-Q 2023-10-25
Quarterly 2022-09-30 958000000.0 +17.0% USD 10-Q 2023-10-25
Quarterly 2023-03-31 466000000.0 -51.4% USD 10-Q 2024-10-22
Quarterly 2023-06-30 356000000.0 -23.6% USD 10-Q 2024-10-22
Quarterly 2023-09-30 478000000.0 +34.3% USD 10-Q 2024-10-22
Quarterly 2024-03-31 53000000.0 -88.9% USD 10-Q 2025-10-23
Quarterly 2024-06-30 737000000.0 +1290.6% USD 10-Q 2025-10-23
Quarterly 2024-09-30 1099000000.0 +49.1% USD 10-Q 2025-10-23
Quarterly 2025-03-31 750000000.0 -31.8% USD 10-Q 2025-10-23
Quarterly 2025-06-30 768000000.0 +2.4% USD 10-Q 2025-10-23
Quarterly 2025-09-30 711000000.0 -7.4% USD 10-Q 2025-10-23
Annual 2016-12-31 1668000000.0 — USD 10-K 2019-02-08
Annual 2017-12-31 5404000000.0 +224.0% USD 10-K 2020-02-06
Annual 2018-12-31 2666000000.0 -50.7% USD 10-K 2021-02-04
Annual 2019-12-31 2722000000.0 +2.1% USD 10-K 2022-02-04
Annual 2020-12-31 2013000000.0 -26.0% USD 10-K 2023-02-03
Annual 2021-12-31 3005000000.0 +49.3% USD 10-K 2024-02-05
Annual 2022-12-31 3270000000.0 +8.8% USD 10-K 2025-02-10
Annual 2023-12-31 1827000000.0 -44.1% USD 10-K 2026-02-09
Annual 2024-12-31 2622000000.0 +43.5% USD 10-K 2026-02-09
Annual 2025-12-31 2873000000.0 +9.6% USD 10-K 2026-02-09

EPS Basic

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2016-03-31 1.3 — USD/shares 10-Q 2017-04-26
Quarterly 2016-06-30 1.37 +5.4% USD/shares 10-Q 2017-07-26
Quarterly 2016-09-30 1.56 +13.9% USD/shares 10-Q 2017-10-25
Quarterly 2017-03-31 1.49 -4.5% USD/shares 10-Q 2018-04-25
Quarterly 2017-06-30 1.72 +15.4% USD/shares 10-Q 2018-07-25
Quarterly 2017-09-30 1.76 +2.3% USD/shares 10-Q 2018-10-24
Quarterly 2018-03-31 1.94 +10.2% USD/shares 10-Q 2019-04-24
Quarterly 2018-06-30 2.52 +29.9% USD/shares 10-Q 2019-07-24
Quarterly 2018-09-30 2.54 +0.8% USD/shares 10-Q 2019-10-23
Quarterly 2019-03-31 2.53 -0.4% USD/shares 10-Q 2020-04-29
Quarterly 2019-06-30 2.72 +7.5% USD/shares 10-Q 2020-07-29
Quarterly 2019-09-30 2.5 -8.1% USD/shares 10-Q 2020-10-28
Quarterly 2020-03-31 1.48 -40.8% USD/shares 10-Q 2021-04-28
Quarterly 2020-06-30 1.53 +3.4% USD/shares 10-Q 2021-07-28
Quarterly 2020-09-30 2.23 +45.8% USD/shares 10-Q 2021-10-27
Quarterly 2021-03-31 2.67 +19.7% USD/shares 10-Q 2022-04-27
Quarterly 2021-06-30 3.29 +23.2% USD/shares 10-Q 2022-07-27
Quarterly 2021-09-30 3.07 -6.7% USD/shares 10-Q 2022-10-26
Quarterly 2022-03-31 2.94 -4.2% USD/shares 10-Q 2023-04-26
Quarterly 2022-06-30 3.46 +17.7% USD/shares 10-Q 2023-07-27
Quarterly 2022-09-30 4.11 +18.8% USD/shares 10-Q 2023-10-25
Quarterly 2023-03-31 2.04 -50.4% USD/shares 10-Q 2024-04-24
Quarterly 2023-06-30 1.56 -23.5% USD/shares 10-Q 2024-07-26
Quarterly 2023-09-30 2.11 +35.3% USD/shares 10-Q 2024-10-22
Quarterly 2024-03-31 0.23 -89.1% USD/shares 10-Q 2025-04-23
Quarterly 2024-06-30 3.26 +1317.4% USD/shares 10-Q 2025-07-29
Quarterly 2024-09-30 4.86 +49.1% USD/shares 10-Q 2025-10-23
Quarterly 2025-03-31 3.31 -31.9% USD/shares 10-Q 2025-04-23
Quarterly 2025-06-30 3.41 +3.0% USD/shares 10-Q 2025-07-29
Quarterly 2025-09-30 3.16 -7.3% USD/shares 10-Q 2025-10-23
Annual 2016-12-31 5.66 — USD/shares 10-K 2019-02-08
Annual 2017-12-31 18.76 +231.4% USD/shares 10-K 2020-02-06
Annual 2018-12-31 9.58 -48.9% USD/shares 10-K 2021-02-04
Annual 2019-12-31 10.32 +7.7% USD/shares 10-K 2022-02-04
Annual 2020-12-31 7.88 -23.6% USD/shares 10-K 2023-02-03
Annual 2021-12-31 12.16 +54.3% USD/shares 10-K 2024-02-05
Annual 2022-12-31 13.92 +14.5% USD/shares 10-K 2025-02-10
Annual 2023-12-31 8.04 -42.2% USD/shares 10-K 2026-02-09
Annual 2024-12-31 11.58 +44.0% USD/shares 10-K 2026-02-09
Annual 2025-12-31 12.76 +10.2% USD/shares 10-K 2026-02-09

EPS Diluted

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2016-03-31 1.29 — USD/shares 10-Q 2017-04-26
Quarterly 2016-06-30 1.36 +5.4% USD/shares 10-Q 2017-07-26
Quarterly 2016-09-30 1.55 +14.0% USD/shares 10-Q 2017-10-25
Quarterly 2017-03-31 1.48 -4.5% USD/shares 10-Q 2018-04-25
Quarterly 2017-06-30 1.71 +15.5% USD/shares 10-Q 2018-07-25
Quarterly 2017-09-30 1.75 +2.3% USD/shares 10-Q 2018-10-24
Quarterly 2018-03-31 1.93 +10.3% USD/shares 10-Q 2019-04-24
Quarterly 2018-06-30 2.5 +29.5% USD/shares 10-Q 2019-07-24
Quarterly 2018-09-30 2.52 +0.8% USD/shares 10-Q 2019-10-23
Quarterly 2019-03-31 2.51 -0.4% USD/shares 10-Q 2020-04-29
Quarterly 2019-06-30 2.7 +7.6% USD/shares 10-Q 2020-07-29
Quarterly 2019-09-30 2.49 -7.8% USD/shares 10-Q 2020-10-28
Quarterly 2020-03-31 1.47 -41.0% USD/shares 10-Q 2021-04-28
Quarterly 2020-06-30 1.53 +4.1% USD/shares 10-Q 2021-07-28
Quarterly 2020-09-30 2.22 +45.1% USD/shares 10-Q 2021-10-27
Quarterly 2021-03-31 2.66 +19.8% USD/shares 10-Q 2022-04-27
Quarterly 2021-06-30 3.28 +23.3% USD/shares 10-Q 2022-07-27
Quarterly 2021-09-30 3.06 -6.7% USD/shares 10-Q 2022-10-26
Quarterly 2022-03-31 2.93 -4.2% USD/shares 10-Q 2023-04-26
Quarterly 2022-06-30 3.45 +17.7% USD/shares 10-Q 2023-07-27
Quarterly 2022-09-30 4.1 +18.8% USD/shares 10-Q 2023-10-25
Quarterly 2023-03-31 2.04 -50.2% USD/shares 10-Q 2024-04-24
Quarterly 2023-06-30 1.56 -23.5% USD/shares 10-Q 2024-07-26
Quarterly 2023-09-30 2.1 +34.6% USD/shares 10-Q 2024-10-22
Quarterly 2024-03-31 0.23 -89.0% USD/shares 10-Q 2025-04-23
Quarterly 2024-06-30 3.25 +1313.0% USD/shares 10-Q 2025-07-29
Quarterly 2024-09-30 4.85 +49.2% USD/shares 10-Q 2025-10-23
Quarterly 2025-03-31 3.31 -31.8% USD/shares 10-Q 2025-04-23
Quarterly 2025-06-30 3.41 +3.0% USD/shares 10-Q 2025-07-29
Quarterly 2025-09-30 3.16 -7.3% USD/shares 10-Q 2025-10-23
Annual 2016-12-31 5.62 — USD/shares 10-K 2019-02-08
Annual 2017-12-31 18.61 +231.1% USD/shares 10-K 2020-02-06
Annual 2018-12-31 9.51 -48.9% USD/shares 10-K 2021-02-04
Annual 2019-12-31 10.25 +7.8% USD/shares 10-K 2022-02-04
Annual 2020-12-31 7.84 -23.5% USD/shares 10-K 2023-02-03
Annual 2021-12-31 12.11 +54.5% USD/shares 10-K 2024-02-05
Annual 2022-12-31 13.88 +14.6% USD/shares 10-K 2025-02-10
Annual 2023-12-31 8.02 -42.2% USD/shares 10-K 2026-02-09
Annual 2024-12-31 11.57 +44.3% USD/shares 10-K 2026-02-09
Annual 2025-12-31 12.75 +10.2% USD/shares 10-K 2026-02-09

8-K Material Event Details

73 filings · 179 item records

This 8-K section tracks corporate event disclosures, not insider buy/sell sentiment. Insider trading direction is shown in the insider section below.

Event Type Distribution

Count per 8-K item

Insider Transaction History

295 transaction records

Net Insider Flow

Monthly open-market buy value minus open-market sell value

Monthly Insider Activity Mix

Share volume split between open-market trades, grants, and exercises

Transaction Value Timeline

Each circle = one priced transaction; size ∝ value

All Transactions

Date Insider Title Type Security Shares Price Total Value Post-Tx Shares
2026-03-31 Huffard John C Jr Dir Equity grant / award
A · derivative
 Deferred Stock Units - Dir. Def. Fee Plan 185 $287.00 $53,000 2,942
2026-02-20 Ryerkerk Lori Dir Equity grant / award
A · derivative
 Restricted Stock Units 3 $315.71 $965 1,340
2026-01-30 LAMPHERE GILBERT H Dir Exercise / conversion
M · derivative
 Restricted Stock Units 700 — — 622
2026-01-30 LAMPHERE GILBERT H Dir Equity grant / award
A · derivative
 Restricted Stock Units 622 — — 1,322
2026-01-30 LAMPHERE GILBERT H Dir Exercise / conversion
M
 Common Stock 700 $0.00 $0 3,647
2026-01-27 George Mark R President & CEO Exercise / conversion
M · derivative
 Restricted Stock Units 775 — — 17,010
2026-01-27 George Mark R President & CEO Other disposed transaction
F
 Common Stock 303 $289.90 $87,841 18,918
2026-01-27 George Mark R President & CEO Exercise / conversion
M
 Common Stock 775 $0.00 $0 19,221
2026-01-26 George Mark R President & CEO Exercise / conversion
M · derivative
 Restricted Stock Units 625 — — 17,785
2026-01-26 George Mark R President & CEO Other disposed transaction
F
 Common Stock 245 $288.31 $70,637 18,446
2026-01-26 George Mark R President & CEO Exercise / conversion
M
 Common Stock 625 $0.00 $0 18,691
2025-12-31 Huffard John C Jr Dir Equity grant / award
A · derivative
 Deferred Stock Units - Dir. Def. Fee Plan 184 $288.72 $53,000 2,745
2025-12-05 Clyburn William Jr. Dir Open-market buy
P
 Common Stock 204 $294.79 $60,137 405
2025-11-20 Ryerkerk Lori Dir Equity grant / award
A · derivative
 Restricted Stock Units 3 $282.86 $969 714
2025-11-19 Bhatt Anil EVP & CIDO Open-market sell
S
 Common Stock 900 $281.60 $253,442 1,413
2025-11-05 Fahmy Sameh Dir Open-market buy
P
 Common Stock 1,650 $282.97 $466,900 12,000
2025-10-27 ANDERSON RICHARD H Dir Open-market buy
P
 Common Stock 2,600 $281.86 $732,823 7,000
2025-10-24 Zampi Jason Andrew EVP & CFO Exercise / conversion
M · derivative
 Restricted Stock Units 150 — — 3,945
2025-10-24 Zampi Jason Andrew EVP & CFO Other disposed transaction
F
 Common Stock 42 $282.50 $11,865 3,025
2025-10-24 Zampi Jason Andrew EVP & CFO Exercise / conversion
M
 Common Stock 150 $0.00 $0 3,067
2025-09-30 Huffard John C Jr Dir Equity grant / award
A · derivative
 Deferred Stock Units - Dir. Def. Fee Plan 176 $300.41 $53,000 2,549
2025-09-13 George Mark R President & CEO Exercise / conversion
M · derivative
 Restricted Stock Units 2,653 — — 18,410
2025-09-13 George Mark R President & CEO Other disposed transaction
F
 Common Stock 1,039 $275.00 $285,720 18,066
2025-09-13 George Mark R President & CEO Exercise / conversion
M
 Common Stock 2,653 $0.00 $0 19,105
2025-08-20 Huffard John C Jr Dir Equity grant / award
A · derivative
 Restricted Stock Units 21 $286.87 $6,161 4,585
2025-08-20 Huffard John C Jr Dir Equity grant / award
A · derivative
 Deferred Stock Units - Dir. Def. Fee Plan 11 $285.49 $3,189 2,373
2025-08-01 LAMPHERE GILBERT H Dir Exercise / conversion
M · derivative
 Restricted Stock Units 460 — — 700
2025-08-01 LAMPHERE GILBERT H Dir Exercise / conversion
M
 Common Stock 460 $0.00 $0 2,947
2025-07-31 ANDERSON RICHARD H Dir Equity grant / award
A · derivative
 Restricted Stock Units 200 — — 1,378
2025-05-20 Davidson Phillip S Dir Equity grant / award
A · derivative
 Restricted Stock Units 10 $243.94 $2,496 1,859
2025-04-26 Orr John F EVP & Chief Operating Officer Exercise / conversion
M · derivative
 Restricted Stock Units 9,021 — — 21,159
2025-04-26 Orr John F EVP & Chief Operating Officer Other disposed transaction
F
 Common Stock 3,825 $223.65 $855,461 5,196
2025-04-26 Orr John F EVP & Chief Operating Officer Exercise / conversion
M
 Common Stock 9,021 $0.00 $0 9,021
2025-03-31 Huffard John C Jr Dir Equity grant / award
A · derivative
 Deferred Stock Units - Dir. Def. Fee Plan 203 $236.85 $48,000 2,143
2025-02-20 KELLEHER THOMAS COLM Dir Equity grant / award
A · derivative
 Restricted Stock Units 31 $248.00 $7,721 5,751
2025-02-20 KELLEHER THOMAS COLM Dir Equity grant / award
A · derivative
 Deferred Stock Units - Dir. Def. Fee Plan 10 $249.41 $2,471 1,840
2025-01-30 George Mark R President & CEO Exercise / conversion
M · derivative
 Restricted Stock Units 712 — — 13,103
2025-01-30 George Mark R President & CEO Equity grant / award
A · derivative
 Restricted Stock Units 8,940 — — 13,815
2025-01-30 George Mark R President & CEO Equity grant / award
A · derivative
 Option (right to buy, granted 2025) 26,337 — $6,775,457 26,337
2025-01-30 George Mark R President & CEO Other disposed transaction
F
 Common Stock 651 $257.26 $167,476 16,452
2025-01-30 George Mark R President & CEO Other disposed transaction
F
 Common Stock 280 $257.26 $72,033 17,103
2025-01-30 George Mark R President & CEO Exercise / conversion
M
 Common Stock 712 $0.00 $0 17,383
2025-01-30 George Mark R President & CEO Equity grant / award
A
 Common Stock 1,638 $0.00 $0 16,671
2025-01-28 Zampi Jason Andrew EVP & CFO Exercise / conversion
M · derivative
 Restricted Stock Units 249 — — 2,326
2025-01-28 Zampi Jason Andrew EVP & CFO Other disposed transaction
F
 Common Stock 69 $255.60 $17,636 2,636
2025-01-28 Zampi Jason Andrew EVP & CFO Exercise / conversion
M
 Common Stock 249 $0.00 $0 2,705
2025-01-27 Zampi Jason Andrew EVP & CFO Exercise / conversion
M · derivative
 Restricted Stock Units 220 — — 2,575
2025-01-27 Zampi Jason Andrew EVP & CFO Other disposed transaction
F
 Common Stock 61 $257.17 $15,687 2,456
2025-01-27 Zampi Jason Andrew EVP & CFO Exercise / conversion
M
 Common Stock 220 $0.00 $0 2,517
2025-01-26 Zampi Jason Andrew EVP & CFO Exercise / conversion
M · derivative
 Restricted Stock Units 247 — — 2,795
2025-01-26 Zampi Jason Andrew EVP & CFO Other disposed transaction
F
 Common Stock 68 $253.65 $17,248 2,297
2025-01-26 Zampi Jason Andrew EVP & CFO Exercise / conversion
M
 Common Stock 247 $0.00 $0 2,365
2024-12-31 Huffard John C Jr Dir Equity grant / award
A · derivative
 Deferred Stock Units - Dir. Def. Fee Plan 205 $234.70 $48,000 1,930
2024-12-13 ANDERSON RICHARD H Dir Open-market buy
P
 Common Stock 200 $248.60 $49,721 4,400
2024-12-12 Fahmy Sameh Dir Open-market buy
P
 Common Stock 350 $249.37 $87,280 10,350
2024-12-11 George Mark R President & CEO Open-market buy
P
 Common Stock 200 $249.84 $49,967 13,757
2024-11-20 MONGEAU CLAUDE Dir Equity grant / award
A · derivative
 Restricted Stock Units 23 $259.89 $5,969 4,445
2024-10-24 Bhatt Anil EVP & CIDO Equity grant / award
A · derivative
 Restricted Stock Units 880 — — 10,660
2024-10-24 Bhatt Anil EVP & CIDO Equity grant / award
A · derivative
 Restricted Stock Units 9,780 — — 9,780
2024-10-24 Bhatt Anil EVP & CIDO Equity grant / award
A · derivative
 Option (right to buy, granted 2024) 2,850 — $728,175 2,850
2024-09-30 Huffard John C Jr Dir Equity grant / award
A · derivative
 Deferred Stock Units - Dir. Def. Fee Plan 193 $248.50 $48,000 1,716
2024-09-13 Shaw Alan H. — Exercise / conversion
M · derivative
 Option (right to buy, granted 2023) 8,055 $255.98 $2,061,939 0
2024-09-13 Shaw Alan H. — Exercise / conversion
M · derivative
 Option (right to buy, granted 2020) 2,960 $255.98 $757,708 0
2024-09-13 Shaw Alan H. — Exercise / conversion
M · derivative
 Option (right to buy, granted 2019) 3,400 $255.93 $870,145 0
2024-09-13 Shaw Alan H. — Exercise / conversion
M · derivative
 Option (right to buy, granted 2018) 3,480 $255.98 $890,819 0
2024-09-13 Shaw Alan H. — Exercise / conversion
M · derivative
 Option (right to buy, granted 2017) 13,220 $255.98 $3,384,089 0
2024-09-13 Shaw Alan H. — Exercise / conversion
M · derivative
 Option (right to buy, granted 2016) 20,210 $255.98 $5,173,406 0
2024-09-13 Shaw Alan H. — Open-market sell
S
 Common Stock 51,325 $255.98 $13,138,302 35,045
2024-09-13 Shaw Alan H. — Exercise / conversion
M
 Common Stock 2,960 $214.50 $634,920 86,370
2024-09-13 Shaw Alan H. — Exercise / conversion
M
 Common Stock 3,400 $165.79 $563,686 83,410
2024-09-13 Shaw Alan H. — Exercise / conversion
M
 Common Stock 3,480 $149.58 $520,538 80,010
2024-09-13 Shaw Alan H. — Exercise / conversion
M
 Common Stock 8,055 $241.18 $1,942,705 76,530
2024-09-13 Shaw Alan H. — Exercise / conversion
M
 Common Stock 13,220 $120.25 $1,589,705 68,475
2024-09-13 Shaw Alan H. — Exercise / conversion
M
 Common Stock 20,210 $70.32 $1,421,167 55,255
2024-08-22 Fahmy Sameh Dir Equity grant / award
A
 Common Stock 1,000 $237.75 $237,750 9,000
2024-08-20 MONGEAU CLAUDE Dir Equity grant / award
A · derivative
 Restricted Stock Units 25 $241.31 $5,936 4,422
2024-08-02 Fahmy Sameh Dir Open-market buy
P
 Common Stock 300 $241.65 $72,494 8,000
2024-08-01 Fahmy Sameh Dir Open-market buy
P
 Common Stock 700 $245.15 $171,603 7,700
2024-07-31 DeBiase Francesca A. Dir Exercise / conversion
M · derivative
 Restricted Stock Units 350 — — 769
2024-07-31 DeBiase Francesca A. Dir Exercise / conversion
M
 Common Stock 350 $0.00 $0 350
2024-07-29 Nag Nabanita C EVP Corp Affairs, CLO&Corp Sec Open-market sell
S
 Common Stock 355 $249.38 $88,530 1,488
2024-06-14 Fahmy Sameh Dir Open-market buy
P
 Common Stock 2,000 $219.25 $438,500 7,000
2024-06-11 Shaw Alan H. President & CEO Equity grant / award
G
 Common Stock 457 $0.00 $0 35,045
2024-06-03 Fahmy Sameh Dir Open-market buy
P
 Common Stock 1,500 $222.17 $333,255 5,000
2024-05-31 Fahmy Sameh Dir Open-market buy
P
 Common Stock 500 $222.20 $111,100 3,500
2024-05-30 KELLEHER THOMAS COLM Dir Open-market buy
P
 Common Stock 1,084 $220.32 $238,831 2,282
2024-05-30 KELLEHER THOMAS COLM Dir Open-market buy
P
 Common Stock 1,198 $219.64 $263,127 1,198
2024-05-29 MONGEAU CLAUDE Dir Open-market buy
P
 Common Stock 5,650 $221.00 $1,248,650 20,000
2024-05-20 MONGEAU CLAUDE Dir Equity grant / award
A · derivative
 Restricted Stock Units 24 $230.34 $5,566 4,147
2024-05-10 Elkins Claude E EVP & Chief Marketing Officer Exercise / conversion
M · derivative
 Option (right to buy, granted 2017) 1,300 $0.00 $0 0
2024-05-10 Elkins Claude E EVP & Chief Marketing Officer Exercise / conversion
M · derivative
 Option (right to buy, granted 2016) 1,230 $0.00 $0 0
2024-05-10 Elkins Claude E EVP & Chief Marketing Officer Exercise / conversion
M · derivative
 Option (right to buy, granted 2015) 1,610 $0.00 $0 0
2024-05-10 Elkins Claude E EVP & Chief Marketing Officer Open-market sell
S
 Common Stock 4,140 $228.81 $947,294 0
2024-05-10 Elkins Claude E EVP & Chief Marketing Officer Open-market sell
S
 Common Stock 3,077 $227.68 $700,565 4,140
2024-05-10 Elkins Claude E EVP & Chief Marketing Officer Open-market sell
S
 Common Stock 1,112 $229.10 $254,759 7,217
2024-05-10 Elkins Claude E EVP & Chief Marketing Officer Exercise / conversion
M
 Common Stock 1,230 $70.32 $86,494 8,329
2024-05-10 Elkins Claude E EVP & Chief Marketing Officer Exercise / conversion
M
 Common Stock 1,300 $120.25 $156,325 7,099
2024-05-10 Elkins Claude E EVP & Chief Marketing Officer Exercise / conversion
M
 Common Stock 1,610 $104.23 $167,810 5,799
2024-04-28 Moore Claiborne L Vice President & Controller Exercise / conversion
M · derivative
 Restricted Stock Units 100 — — 2,448
2024-04-28 Moore Claiborne L Vice President & Controller Other disposed transaction
F
 Common Stock 28 $240.37 $6,730 3,398
2024-04-28 Moore Claiborne L Vice President & Controller Exercise / conversion
M
 Common Stock 100 $0.00 $0 3,426
2024-04-26 Orr John F EVP & Chief Operating Officer Equity grant / award
A · derivative
 Restricted Stock Units 2,810 — — 27,770
2024-04-26 Orr John F EVP & Chief Operating Officer Equity grant / award
A · derivative
 Restricted Stock Units 24,960 — — 24,960
2024-04-26 Orr John F EVP & Chief Operating Officer Equity grant / award
A · derivative
 Option (right to buy, granted 2024) 8,090 — $1,944,674 8,090
2024-03-31 Huffard John C Jr Dir Equity grant / award
A · derivative
 Deferred Stock Units - Dir. Def. Fee Plan 188 $254.87 $48,000 1,284
2024-03-02 Duncan Paul B EVP & Chief Operating Officer Exercise / conversion
M · derivative
 Restricted Stock Units 1,505 — — 4,897
2024-03-02 Duncan Paul B EVP & Chief Operating Officer Other disposed transaction
F
 Common Stock 640 $255.35 $163,424 2,621
2024-03-02 Duncan Paul B EVP & Chief Operating Officer Exercise / conversion
M
 Common Stock 1,505 $0.00 $0 3,261
2024-02-20 THOMPSON JOHN R Dir Equity grant / award
A · derivative
 Restricted Stock Units 73 $254.54 $18,474 13,757
2024-01-30 Adams Ann A EVP & Chief Transform. Officer Exercise / conversion
M · derivative
 Restricted Stock Units 545 — — 6,304
2024-01-30 Adams Ann A EVP & Chief Transform. Officer Equity grant / award
A · derivative
 Restricted Stock Units 2,960 — — 6,849
2024-01-30 Adams Ann A EVP & Chief Transform. Officer Other disposed transaction
F
 Common Stock 1,590 $236.48 $376,003 19,779
2024-01-30 Adams Ann A EVP & Chief Transform. Officer Other disposed transaction
F
 Common Stock 233 $236.48 $55,100 21,369
2024-01-30 Adams Ann A EVP & Chief Transform. Officer Exercise / conversion
M
 Common Stock 545 $0.00 $0 21,602
2024-01-30 Adams Ann A EVP & Chief Transform. Officer Equity grant / award
A
 Common Stock 3,717 $0.00 $0 21,057
2024-01-28 George Mark R EVP & Chief Financial Officer Exercise / conversion
M · derivative
 Restricted Stock Units 702 — — 4,744
2024-01-28 George Mark R EVP & Chief Financial Officer Other disposed transaction
F
 Common Stock 276 $234.30 $64,667 10,635
2024-01-28 George Mark R EVP & Chief Financial Officer Exercise / conversion
M
 Common Stock 702 $0.00 $0 10,911
2024-01-27 George Mark R EVP & Chief Financial Officer Exercise / conversion
M · derivative
 Restricted Stock Units 775 — — 5,446
2024-01-27 George Mark R EVP & Chief Financial Officer Other disposed transaction
F
 Common Stock 305 $231.20 $70,517 10,209
2024-01-27 George Mark R EVP & Chief Financial Officer Exercise / conversion
M
 Common Stock 775 $0.00 $0 10,514
2024-01-26 George Mark R EVP & Chief Financial Officer Exercise / conversion
M · derivative
 Restricted Stock Units 625 — — 6,221
2024-01-26 George Mark R EVP & Chief Financial Officer Other disposed transaction
F
 Common Stock 246 $231.20 $56,876 9,739
2024-01-26 George Mark R EVP & Chief Financial Officer Exercise / conversion
M
 Common Stock 625 $0.00 $0 9,985
2023-12-31 Scanlon Jennifer F. Dir Equity grant / award
A · derivative
 Deferred Stock Units - Dir. Def. Fee Plan 127 $236.38 $30,000 558
2023-11-20 Scanlon Jennifer F. Dir Equity grant / award
A · derivative
 Restricted Stock Units 34 $210.58 $7,077 5,276
2023-11-20 Scanlon Jennifer F. Dir Equity grant / award
A · derivative
 Deferred Stock Units - Dir. Def. Fee Plan 3 $212.12 $579 432
2023-11-09 Adams Ann A EVP & Chief Transform. Officer Exercise / conversion
M · derivative
 Option (right to buy, granted 2017) 2,190 — $263,348 0
2023-11-09 Adams Ann A EVP & Chief Transform. Officer Exercise / conversion
M · derivative
 Option (right to buy, granted 2015) 1,610 — $167,810 0
2023-11-09 Adams Ann A EVP & Chief Transform. Officer Exercise / conversion
M · derivative
 Option (right to buy, granted 08/16/2019) 500 — $86,500 0
2023-11-09 Adams Ann A EVP & Chief Transform. Officer Other disposed transaction
F
 Common Stock 3,174 $194.57 $617,581 16,355
2023-11-09 Adams Ann A EVP & Chief Transform. Officer Equity grant / award
G
 Common Stock 74 $0.00 $0 19,529
2023-11-09 Adams Ann A EVP & Chief Transform. Officer Exercise / conversion
M
 Common Stock 500 $173.00 $86,500 19,603
2023-11-09 Adams Ann A EVP & Chief Transform. Officer Exercise / conversion
M
 Common Stock 1,610 $104.23 $167,810 19,103
2023-11-09 Adams Ann A EVP & Chief Transform. Officer Exercise / conversion
M
 Common Stock 2,190 $120.25 $263,348 17,493
2023-10-27 Duncan Paul B EVP & Chief Operating Officer Exercise / conversion
M · derivative
 Restricted Stock Units 52 — — 4,726
2023-10-27 Duncan Paul B EVP & Chief Operating Officer Other disposed transaction
F
 Common Stock 15 $185.27 $2,779 1,263
2023-10-27 Duncan Paul B EVP & Chief Operating Officer Exercise / conversion
M
 Common Stock 52 $0.00 $0 1,278
2023-09-30 Scanlon Jennifer F. Dir Equity grant / award
A · derivative
 Deferred Stock Units - Dir. Def. Fee Plan 152 $196.93 $30,000 429
2023-08-21 THOMPSON JOHN R Dir Equity grant / award
A · derivative
 Restricted Stock Units 82 $210.87 $17,227 12,842
2023-08-02 Shaw Alan H. President & CEO Equity grant / award
G
 Common Stock 325 $0.00 $0 30,710
2023-07-31 DeBiase Francesca A. Dir Equity grant / award
A · derivative
 Restricted Stock Units 350 — — 350
2023-07-28 Nag Nabanita C EVP & Chief Legal Officer Exercise / conversion
M · derivative
 Restricted Stock Units 145 — — 3,954
2023-07-28 Nag Nabanita C EVP & Chief Legal Officer Other disposed transaction
F
 Common Stock 41 $236.26 $9,687 947
2023-07-28 Nag Nabanita C EVP & Chief Legal Officer Exercise / conversion
M
 Common Stock 145 $0.00 $0 988
2023-06-30 Scanlon Jennifer F. Dir Equity grant / award
A · derivative
 Deferred Stock Units - Dir. Def. Fee Plan 132 $226.76 $30,000 275
2023-06-01 Shaw Alan H. President & CEO Open-market sell
S
 Common Stock 2,000 $209.55 $419,100 30,654
2023-05-20 Scanlon Jennifer F. Dir Equity grant / award
A · derivative
 Restricted Stock Units 32 $217.38 $6,989 5,209
2023-05-20 Scanlon Jennifer F. Dir Equity grant / award
A · derivative
 Deferred Stock Units - Dir. Def. Fee Plan 1 $217.74 $191 142
2023-05-01 Shaw Alan H. President & CEO Equity grant / award
G
 Common Stock 122 $0.00 $0 32,654
2023-04-28 MILES AMY E Dir Equity grant / award
A · derivative
 Restricted Stock Units 490 — — 13,560
2023-03-31 Scanlon Jennifer F. Dir Equity grant / award
A · derivative
 Deferred Stock Units - Dir. Def. Fee Plan 142 $212.00 $30,000 142
2023-03-01 Shaw Alan H. President & CEO Open-market sell
S
 Common Stock 2,000 $224.16 $448,320 32,776
2023-02-21 THOMPSON JOHN R Dir Equity grant / award
A · derivative
 Restricted Stock Units 75 $225.43 $17,019 12,682
2023-01-30 Squires James A Dir Exercise / conversion
M · derivative
 Restricted Stock Units 2,300 — — 9,544
2023-01-30 Squires James A Dir Other disposed transaction
F
 Common Stock 852 $239.06 $203,675 60,907
2023-01-30 Squires James A Dir Exercise / conversion
M
 Common Stock 2,300 $0.00 $0 61,759
2023-01-28 Squires James A Dir Exercise / conversion
M · derivative
 Restricted Stock Units 2,984 — — 11,844
2023-01-28 Squires James A Dir Exercise / conversion
M · derivative
 Restricted Stock Units 2,250 — — 14,828
2023-01-28 Squires James A Dir Other disposed transaction
F
 Common Stock 1,105 $239.06 $264,156 59,459
2023-01-28 Squires James A Dir Other disposed transaction
F
 Common Stock 833 $239.06 $199,133 60,564
2023-01-28 Squires James A Dir Exercise / conversion
M
 Common Stock 2,250 $0.00 $0 61,397
2023-01-28 Squires James A Dir Exercise / conversion
M
 Common Stock 2,984 $0.00 $0 59,147
2023-01-27 LEER STEVEN F Dir Exercise / conversion
M · derivative
 Restricted Stock Units 640 — — 80,261
2023-01-27 LEER STEVEN F Dir Exercise / conversion
M
 Common Stock 640 $0.00 $0 4,470
2023-01-27 Squires James A Dir Exercise / conversion
M · derivative
 Restricted Stock Units 664 — — 17,078
2023-01-27 Squires James A Dir Other disposed transaction
F
 Common Stock 246 $241.20 $59,335 56,163
2023-01-27 Squires James A Dir Exercise / conversion
M
 Common Stock 664 $0.00 $0 56,409
2023-01-26 LEER STEVEN F Dir Equity grant / award
A · derivative
 Restricted Stock Units 750 — — 80,901
2022-12-16 Adams Ann A EVP & Chief Transform. Officer Equity grant / award
G
 Common Stock 10 $0.00 $0 10,998
2022-12-16 Adams Ann A EVP & Chief Transform. Officer Equity grant / award
G
 Common Stock 1 $0.00 $0 11,018
2022-12-09 Shaw Alan H. President & CEO Equity grant / award
G
 Common Stock 105 $0.00 $0 30,053
2022-12-08 Squires James A Dir Open-market sell
S
 Common Stock 10,636 $245.74 $2,613,743 1,001
2022-12-01 Shaw Alan H. President & CEO Open-market sell
S
 Common Stock 2,000 $258.35 $516,700 30,158
2022-11-21 THOMPSON JOHN R Dir Equity grant / award
A · derivative
 Restricted Stock Units 59 $245.99 $14,628 11,856
2022-09-14 Scanlon Jennifer F. Dir Equity grant / award
A
 Common Stock 42 $236.79 $9,945 42
2022-09-01 Shaw Alan H. President & CEO Equity grant / award
G
 Common Stock 97 $0.00 $0 32,158
2022-09-01 Shaw Alan H. President & CEO Open-market sell
S
 Common Stock 2,000 $241.28 $482,560 32,255
2022-08-20 THOMPSON JOHN R Dir Equity grant / award
A · derivative
 Restricted Stock Units 57 $256.50 $14,558 11,797
2022-08-02 Squires James A Dir Exercise / conversion
M · derivative
 Option (right to buy, granted 2016) 105,420 $0.00 $0 0
2022-08-02 Squires James A Dir Open-market sell
S
 Common Stock 52,950 $248.35 $13,150,275 42,728
2022-08-02 Squires James A Dir Open-market sell
S
 Common Stock 46,043 $249.13 $11,470,614 95,678
2022-08-02 Squires James A Dir Open-market sell
S
 Common Stock 6,295 $250.21 $1,575,073 141,721
2022-08-02 Squires James A Dir Open-market sell
S
 Common Stock 132 $250.86 $33,113 148,016
2022-08-02 Squires James A Dir Exercise / conversion
M
 Common Stock 105,420 $70.32 $7,413,134 148,148
2022-07-28 Shaw Alan H. President & CEO Equity grant / award
A · derivative
 Restricted Stock Units 2,670 — — 11,397
2022-07-28 Shaw Alan H. President & CEO Equity grant / award
A · derivative
 Option (right to buy, granted 2022) 5,200 — $1,273,116 5,200
2022-06-01 Shaw Alan H. President & CEO Open-market sell
S
 Common Stock 1,000 $241.84 $241,840 34,255
2022-05-20 THOMPSON JOHN R Dir Equity grant / award
A · derivative
 Restricted Stock Units 64 $226.06 $14,479 11,740
2022-05-16 Squires James A Dir Exercise / conversion
M · derivative
 Option (right to buy, granted 2015) 27,871 — $2,904,994 0
2022-05-16 Squires James A Dir Open-market sell
S
 Common Stock 27,871 $247.54 $6,899,221 62,728
2022-05-16 Squires James A Dir Exercise / conversion
M
 Common Stock 27,871 $104.23 $2,904,994 90,599
2022-04-28 Nag Nabanita C SVP & Chief Legal Officer Equity grant / award
A · derivative
 Restricted Stock Units 680 — — 2,017
2022-04-28 Nag Nabanita C SVP & Chief Legal Officer Equity grant / award
A · derivative
 Option (right to buy, granted 2022) 920 — $244,582 920
2022-03-24 Squires James A Chairman and CEO Equity grant / award
G
 Common Stock 16,000 $0.00 $0 32,613
2022-03-21 Squires James A Chairman and CEO Equity grant / award
G
 Common Stock 7,000 $0.00 $0 41,613
2022-03-21 Squires James A Chairman and CEO Equity grant / award
G
 Common Stock 14,000 $0.00 $0 62,728
2022-03-14 LEER STEVEN F Dir Open-market sell
S
 Common Stock 700 $265.51 $185,856 3,830
2022-03-01 Shaw Alan H. President Open-market sell
S
 Common Stock 1,000 $256.70 $256,700 35,255
2022-02-21 THOMPSON JOHN R Dir Equity grant / award
A · derivative
 Restricted Stock Units 53 $273.12 $14,413 11,676
2022-01-31 Adams Ann A EVP & Chief Transform. Officer Exercise / conversion
M · derivative
 Restricted Stock Units 545 — — 5,110
2022-01-31 Adams Ann A EVP & Chief Transform. Officer Other disposed transaction
F
 Common Stock 152 $270.71 $41,148 9,071
2022-01-31 Adams Ann A EVP & Chief Transform. Officer Exercise / conversion
M
 Common Stock 545 $0.00 $0 9,223
2022-01-31 George Mark R EVP and CFO Other disposed transaction
F
 Common Stock 263 $270.71 $71,197 2,077
2022-01-30 Allison Clyde H Jr Vice President and Controller Exercise / conversion
M · derivative
 Restricted Stock Units 222 — — 446
2022-01-30 Allison Clyde H Jr Vice President and Controller Other disposed transaction
F
 Common Stock 62 $270.71 $16,784 43,433
2022-01-30 Allison Clyde H Jr Vice President and Controller Exercise / conversion
M
 Common Stock 222 $0.00 $0 43,495
2022-01-27 Kleine Lorri J SVP & Chief Legal Officer Equity grant / award
A · derivative
 Option (right to buy, granted 2022) 1,530 — $414,599 1,530
2022-01-27 Kleine Lorri J SVP & Chief Legal Officer Other disposed transaction
F
 Common Stock 122 $270.98 $33,060 2,089
2022-01-27 Kleine Lorri J SVP & Chief Legal Officer Equity grant / award
A
 Common Stock 438 $0.00 $0 2,211
2022-01-26 Shaw Alan H. President Exercise / conversion
M · derivative
 Restricted Stock Units 1,780 — — 0
2022-01-26 Shaw Alan H. President Other disposed transaction
F
 Common Stock 494 $273.06 $134,893 31,681
2022-01-26 Shaw Alan H. President Exercise / conversion
M
 Common Stock 1,780 $0.00 $0 32,175
2022-01-25 Shaw Alan H. President Exercise / conversion
M · derivative
 Restricted Stock Units 729 — — 4,630
2022-01-25 Shaw Alan H. President Other disposed transaction
F
 Common Stock 203 $271.73 $55,161 30,395
2022-01-25 Shaw Alan H. President Exercise / conversion
M
 Common Stock 729 $0.00 $0 30,598
2021-12-31 Huffard John C Jr Dir Equity grant / award
A · derivative
 Deferred Stock Units - Dir. Def. Fee Plan 94 $297.71 $28,125 1,042
2021-12-10 Adams Ann A EVP-Chief Transform. Officer Equity grant / award
G
 Common Stock 2 $0.00 $0 7,117
2021-12-10 Adams Ann A EVP-Chief Transform. Officer Equity grant / award
G
 Common Stock 1 $0.00 $0 7,119
2021-12-06 Adams Ann A EVP-Chief Transform. Officer Equity grant / award
G
 Common Stock 10 $0.00 $0 7,121
2021-12-01 Shaw Alan H. EVP & Chief Marketing Officer Open-market sell
S
 Common Stock 1,000 $272.73 $272,730 29,869
2021-11-19 THOMPSON JOHN R Dir Equity grant / award
A · derivative
 Restricted Stock Units 43 $274.33 $11,925 10,983
2021-10-28 Allison Clyde H Jr Vice President and Controller Exercise / conversion
M · derivative
 Option (right to buy, granted 2013) 5,000 — $349,150 0
2021-10-28 Allison Clyde H Jr Vice President and Controller Open-market sell
S
 Common Stock 5,000 $290.13 $1,450,650 42,250
2021-10-28 Allison Clyde H Jr Vice President and Controller Exercise / conversion
M
 Common Stock 5,000 $69.83 $349,150 47,250
2021-09-30 KELLEHER THOMAS COLM Dir Equity grant / award
A · derivative
 Deferred Stock Units - Dir. Def. Fee Plan 138 $239.25 $33,125 1,595
2021-09-15 Shaw Alan H. EVP & Chief Marketing Officer Open-market sell
S
 Common Stock 1,000 $245.15 $245,150 30,869
2021-08-20 THOMPSON JOHN R Dir Equity grant / award
A · derivative
 Restricted Stock Units 45 $262.65 $11,875 10,940
2021-08-04 Squires James A Chairman, President and CEO Equity grant / award
G
 Common Stock 1,600 $0.00 $0 48,613
2021-07-29 Shaw Alan H. EVP & Chief Marketing Officer Exercise / conversion
M · derivative
 Option (right to buy, granted 2015) 2,720 — $283,506 0
2021-07-29 Shaw Alan H. EVP & Chief Marketing Officer Exercise / conversion
M · derivative
 Option (right to buy, granted 2014) 2,760 — $259,909 0
2021-07-29 Shaw Alan H. EVP & Chief Marketing Officer Exercise / conversion
M · derivative
 Option (right to buy, granted 2013) 2,550 — $178,066 0
2021-07-29 Shaw Alan H. EVP & Chief Marketing Officer Exercise / conversion
M · derivative
 Option (right to buy, granted 2012) 1,900 — $142,766 0
2021-07-29 Shaw Alan H. EVP & Chief Marketing Officer Open-market sell
S
 Common Stock 1,761 $256.94 $452,473 31,869
2021-07-29 Shaw Alan H. EVP & Chief Marketing Officer Open-market sell
S
 Common Stock 1,699 $256.90 $436,479 33,630
2021-07-29 Shaw Alan H. EVP & Chief Marketing Officer Other disposed transaction
F
 Common Stock 1,552 $258.14 $400,633 35,329
2021-07-29 Shaw Alan H. EVP & Chief Marketing Officer Open-market sell
S
 Common Stock 1,118 $256.96 $287,287 36,881
2021-07-29 Shaw Alan H. EVP & Chief Marketing Officer Open-market sell
S
 Common Stock 570 $256.91 $146,438 37,999
2021-07-29 Shaw Alan H. EVP & Chief Marketing Officer Exercise / conversion
M
 Common Stock 1,900 $75.14 $142,766 38,569
2021-07-29 Shaw Alan H. EVP & Chief Marketing Officer Exercise / conversion
M
 Common Stock 2,550 $69.83 $178,066 36,669
2021-07-29 Shaw Alan H. EVP & Chief Marketing Officer Exercise / conversion
M
 Common Stock 2,720 $104.23 $283,506 34,119
2021-07-29 Shaw Alan H. EVP & Chief Marketing Officer Exercise / conversion
M
 Common Stock 2,760 $94.17 $259,909 31,399
2021-06-30 Huffard John C Jr Dir Equity grant / award
A · derivative
 Deferred Stock Units - Dir. Def. Fee Plan 106 $265.41 $28,125 823
2021-06-01 MONGEAU CLAUDE Dir Open-market buy
P
 Common Stock 2,350 $282.69 $664,316 14,350
2021-05-26 Squires James A Chairman, President and CEO Equity grant / award
G
 Common Stock 1,588 $0.00 $0 51,802
2021-05-26 Squires James A Chairman, President and CEO Equity grant / award
G
 Common Stock 1,589 $0.00 $0 50,213
2021-05-24 Squires James A Chairman, President and CEO Open-market sell
S
 Common Stock 10,000 $278.12 $2,781,200 11,637
2021-05-20 Huffard John C Jr Dir Equity grant / award
A · derivative
 Restricted Stock Units 5 $277.88 $1,435 1,454
2021-05-20 Huffard John C Jr Dir Equity grant / award
A · derivative
 Deferred Stock Units - Dir. Def. Fee Plan 3 $276.91 $707 717
2021-05-18 Squires James A Chairman, President and CEO Exercise / conversion
M · derivative
 Option (right to buy, granted 2015) 70,000 — $6,493,200 62,880
2021-05-18 Squires James A Chairman, President and CEO Open-market sell
S
 Common Stock 70,000 $282.21 $19,754,833 50,211
2021-05-18 Squires James A Chairman, President and CEO Exercise / conversion
M
 Common Stock 70,000 $92.76 $6,493,200 120,211
2021-05-11 Allison Clyde H Jr Vice President and Controller Exercise / conversion
M · derivative
 Option (right to buy, granted 2012) 3,700 — $278,018 0
2021-05-11 Allison Clyde H Jr Vice President and Controller Open-market sell
S
 Common Stock 3,700 $288.30 $1,066,710 41,932
2021-05-11 Allison Clyde H Jr Vice President and Controller Exercise / conversion
M
 Common Stock 3,700 $75.14 $278,018 45,632
2021-03-31 KELLEHER THOMAS COLM Dir Equity grant / award
A · derivative
 Deferred Stock Units - Dir. Def. Fee Plan 123 $268.52 $33,125 1,321
2021-03-10 THOMPSON JOHN R Dir Equity grant / award
A · derivative
 Restricted Stock Units 41 $260.38 $10,707 10,856
2021-03-09 Squires James A Chairman, President and CEO Equity grant / award
G
 Common Stock 16,439 $0.00 $0 50,231
2021-03-09 Squires James A Chairman, President and CEO Equity grant / award
G
 Common Stock 17 $0.00 $0 50,214
2021-02-24 Squires James A Chairman, President and CEO Equity grant / award
G
 Common Stock 3,000 $0.00 $0 33,792
2021-02-19 Adams Ann A EVP-Chief Transform. Officer Exercise / conversion
M · derivative
 Option (right to buy, granted 2016) 2,460 — $172,987 0
2021-02-19 Adams Ann A EVP-Chief Transform. Officer Open-market sell
S
 Common Stock 2,460 $255.00 $627,300 7,141
2021-02-19 Adams Ann A EVP-Chief Transform. Officer Exercise / conversion
M
 Common Stock 2,460 $70.32 $172,987 9,601
2021-02-11 Squires James A Chairman, President and CEO Equity grant / award
G
 Common Stock 2,200 $0.00 $0 36,792
2021-02-01 Shaw Alan H. EVP & Chief Marketing Officer Open-market sell
S
 Common Stock 43 $239.58 $10,302 0
2021-02-01 Adams Ann A EVP-Chief Transform. Officer Exercise / conversion
M · derivative
 Restricted Stock Units 545 — — 4,616
2021-02-01 Adams Ann A EVP-Chief Transform. Officer Open-market sell
S
 Common Stock 1,417 $239.00 $338,663 7,141
2021-02-01 Adams Ann A EVP-Chief Transform. Officer Other disposed transaction
F
 Common Stock 152 $239.51 $36,406 8,558
2021-02-01 Adams Ann A EVP-Chief Transform. Officer Exercise / conversion
M
 Common Stock 545 $0.00 $0 8,710
2021-02-01 Shaw Alan H. EVP & Chief Marketing Officer Other disposed transaction
F
 Common Stock 233 $239.51 $55,807 28,639
2021-01-28 Sanborn Cynthia M EVP & Chief Operating Officer Equity grant / award
A · derivative
 Restricted Stock Units 3,130 — — 12,510
2021-01-28 Sanborn Cynthia M EVP & Chief Operating Officer Equity grant / award
A · derivative
 Option (right to buy, granted 2021) 5,150 — $1,245,218 5,150
2021-01-25 Allison Clyde H Jr Vice President and Controller Exercise / conversion
M · derivative
 Restricted Stock Units 315 — — 315
2021-01-25 Allison Clyde H Jr Vice President and Controller Other disposed transaction
F
 Common Stock 88 $243.28 $21,409 40,118
2021-01-25 Allison Clyde H Jr Vice President and Controller Exercise / conversion
M
 Common Stock 315 $0.00 $0 40,206
2021-01-08 Shaw Alan H. EVP & Chief Marketing Officer Open-market buy
P
 Common Stock 17 $255.16 $4,338 43
2021-01-07 Shaw Alan H. EVP & Chief Marketing Officer Open-market buy
P
 Common Stock 8 $247.66 $1,981 26
2021-01-06 Shaw Alan H. EVP & Chief Marketing Officer Open-market buy
P
 Common Stock 8 $241.15 $1,929 18
2021-01-05 Shaw Alan H. EVP & Chief Marketing Officer Open-market buy
P
 Common Stock 10 $235.66 $2,357 10
2020-12-31 KELLEHER THOMAS COLM Dir Equity grant / award
A · derivative
 Deferred Stock Units - Dir. Def. Fee Plan 139 $237.61 $33,125 1,193
2020-12-10 THOMPSON JOHN R Dir Equity grant / award
A · derivative
 Restricted Stock Units 40 $238.09 $9,452 10,095
2020-10-05 Shaw Alan H. EVP & Chief Marketing Officer Open-market sell
S
 Common Stock 8 $215.45 $1,724 0
2020-10-02 Shaw Alan H. EVP & Chief Marketing Officer Open-market sell
S
 Common Stock 43 $213.39 $9,176 8
2020-09-02 Shaw Alan H. EVP & Chief Marketing Officer Open-market sell
S
 Common Stock 12 $214.67 $2,576 51
2020-08-04 Shaw Alan H. EVP & Chief Marketing Officer Open-market sell
S
 Common Stock 7 $190.51 $1,334 63
2020-06-04 Shaw Alan H. EVP & Chief Marketing Officer Open-market buy
P
 Common Stock 6 $191.89 $1,151 70
2020-06-03 Shaw Alan H. EVP & Chief Marketing Officer Open-market buy
P
 Common Stock 6 $191.46 $1,149 64
2020-06-02 Shaw Alan H. EVP & Chief Marketing Officer Open-market buy
P
 Common Stock 7 $183.40 $1,284 58
2020-05-27 Shaw Alan H. EVP & Chief Marketing Officer Exercise / conversion
M · derivative
 Option (right to buy, granted 2011) 1,593 — $99,953 0
2020-05-27 Shaw Alan H. EVP & Chief Marketing Officer Other disposed transaction
F
 Common Stock 545 $183.50 $100,005 22,278
2020-05-27 Shaw Alan H. EVP & Chief Marketing Officer Exercise / conversion
M
 Common Stock 1,593 $62.74 $99,953 22,670
2020-05-27 Shaw Alan H. EVP & Chief Marketing Officer Open-market sell
S
 Common Stock 254 $184.21 $46,788 21,230
2020-04-06 Shaw Alan H. EVP & Chief Marketing Officer Open-market buy
P
 Common Stock 4 $153.57 $614 51
2020-04-03 Shaw Alan H. EVP & Chief Marketing Officer Open-market buy
P
 Common Stock 26 $142.34 $3,701 47
2020-04-02 Shaw Alan H. EVP & Chief Marketing Officer Open-market buy
P
 Common Stock 21 $141.73 $2,976 21

Regulatory Activity

Last 12 months to 2025-04-29
Insider Filings (Forms 3/4/5) — 12 months
18
Material Event Filings (8-K) — 12 months
15

8-K Material Event Filing Activity

Monthly count

Insider Trading Activity (Forms 3/4/5)

Monthly count
For informational purposes only — not guaranteed to be accurate or complete.